Argatroban is an anticoagulant that is a small molecule direct thrombin inhibitor. In 2000, argatroban was licensed by the Food and Drug Administration (FDA) for prophylaxis or treatment of thrombosis in patients with heparin-induced thrombocytopenia (HIT). In 2002, it was approved for use during percutaneous coronary interventions in patients who have HIT or are at risk for developing it. more on Wikipedia

Fast Facts:

  • Administered intravenously.
  • Discuss all medications you are taking with your physician prior to starting your treatment.
  • Some side effects include nausea, vomiting and diarrhea.
  • More serious side effects include rash, hives and chest pain, and should be reported to your doctor immediately.